Episode 23: Dr. Ching-Wei Tzeng – HPB Education, Quality Improvement, and Preoperative Use of Y-90 in CRLM

Today’s episode features Dr. Ching-Wei Tzeng.  Dr. Tzeng is a hepatobiliary surgeon and Associate Professor of Surgical Oncology at MD Anderson.  Among many roles, he is the Department Vice Chair of Clinical Operations and Program Director for the HPB Surgery Fellowship.

Dr. Tzeng is an accomplished researcher.  His interests focus on multimodality therapy for GI Cancers and perioperative quality improvement, including cancer surgery standards, patient-centered opioid reduction protocols, and quality of life measures.  Dr. Tzeng is a passionate surgical educator and has been widely recognized with numerous teaching awards.

In this episode we discuss topics including surgical education, quality improvement from the surgeon to institution level, and much more.  Enjoy!

Papers/Trials Referenced in the Episode:

1. DiPeri TP, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CD. Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg. 2022 Jul 1;235(1):41-48. doi: 10.1097/XCS.0000000000000231. Epub 2022 Apr 11. PMID: 35703961; PMCID: PMC9205619.
2. Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, Tzeng CD. Assessing the 5×-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient Surgery. JAMA Surg. 2020 Dec 1;155(12):1166-1167. doi: 10.1001/jamasurg.2020.3527. PMID: 32997105; PMCID: PMC7527936.
3. Preoperative Y90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients with Colorectal Liver Metastases: https://classic.clinicaltrials.gob/ct2/show/NCT05195710